South Bow price target cut to $33 by Barclays
Barclays cut its rating on South Bow to underweight and lowered its price target to $33.00 from $35.00, according to a Benzinga ratings recap.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Barclays cut its rating on South Bow to underweight and lowered its price target to $33.00 from $35.00, according to a Benzinga ratings recap.
Sanofi (NASDAQ: SNY ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Sanofi delivered a stro